This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Agency for Science, Technology and Research. Active years: 2012-2018.
Company Filing History:
Years Active: 2012-2018
Title: Wing-Kin Sung: Innovator in Hepatitis B Research and Nucleic Acid Detection
Introduction
Wing-Kin Sung is a prominent inventor based in Singapore, known for his contributions to medical research and technology. He has been instrumental in developing methods that enhance the understanding and treatment of diseases, particularly those related to Hepatitis B and nucleic acid detection.
Latest Patents
Wing-Kin Sung holds 2 patents that reflect his innovative approach to medical science. His latest patents include a method for predicting the prognosis of hepatocellular carcinoma patients based on the detection of Hepatitis B virus (HBV). This method involves determining the HBV genotype and identifying the strain integrated into the genome of biological samples. Additionally, he has developed a method for designing oligonucleotides for nucleic acid detection, which includes steps for amplifying nucleic acids and detecting pathogens in human biological samples.
Career Highlights
Wing-Kin Sung is affiliated with the Agency for Science, Technology and Research, where he applies his expertise in research and development. His work has significantly advanced the field of medical diagnostics, particularly in understanding the clinical outcomes of patients with liver cancer.
Collaborations
He has collaborated with notable colleagues, including Christopher Wing Cheong Wong and Charlie Lee, to further enhance the impact of his research in the scientific community.
Conclusion
Wing-Kin Sung's innovative contributions to medical research and technology have made a significant impact on the understanding of Hepatitis B and nucleic acid detection. His work continues to pave the way for advancements in medical diagnostics and treatment options.